OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Showing 6 citing articles:
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
Valentín García‐Gutiérrez, Massimo Breccia, Elias Jabbour, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Valentín García‐Gutiérrez, Massimo Breccia, Elias Jabbour, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
Elena Inzoli, Andrea Aroldi, Rocco Piazza, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8, pp. 1075-1085
Open Access | Times Cited: 21
Elena Inzoli, Andrea Aroldi, Rocco Piazza, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8, pp. 1075-1085
Open Access | Times Cited: 21
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
Sílvia Marcé, Aleix Méndez López, Blanca Xicoy, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 779-779
Open Access | Times Cited: 3
Sílvia Marcé, Aleix Méndez López, Blanca Xicoy, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 779-779
Open Access | Times Cited: 3
Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre
Rup Jyoti Sarma, Lakhan Kashyap, Anne Srikanth, et al.
Indian Journal of Hematology and Blood Transfusion (2024) Vol. 40, Iss. 4, pp. 564-572
Closed Access | Times Cited: 3
Rup Jyoti Sarma, Lakhan Kashyap, Anne Srikanth, et al.
Indian Journal of Hematology and Blood Transfusion (2024) Vol. 40, Iss. 4, pp. 564-572
Closed Access | Times Cited: 3
Advances in the Treatment of Chronic Myeloid Leukemia
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 1-17
Closed Access
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 1-17
Closed Access
Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey
Hong Chen, Yuming Zhang, Yirong Jiang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 8, pp. 1458-1464
Closed Access
Hong Chen, Yuming Zhang, Yirong Jiang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 8, pp. 1458-1464
Closed Access
